Research

Adherence

GLP-1 RAs are associated with an increased risk of suicidal behavior and self-harm, particularly in patients with underlying mental health vulnerabilities or dysphoria.

If you are taking Semaglutide and experience mood changes, depression, or suicidal thoughts, contact your healthcare provider immediately. Do not ignore these symptoms. Regular screening for mental health is recommended for all patients on this medication.

LimitedQualifiesLOW confidence
A possible link between GLP-1 RAs and suicidal behavior has been proposed... growing numbers of studies have found an association between GLP-1 RAs and possible self-injury thoughts... the current case report may serve as evidence of GLP-1 RAs overdose that raises suspicions regarding self-overdosing this medication in attempting suicide.
Doron Zamir et al. · American Journal of Case Reports · 2025

Why this rating

Based on a single case report and references to other studies/reports, not a large-scale controlled trial.

Source

Semaglutide Overdose in a Diabetic Patient: Suicidal Behavior and Multiorgan Failure

Doron Zamir et al. · American Journal of Case Reports · 2025

DOI 10.12659/ajcr.947682

case_report · n=1Cited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →